Agent consensus
OVERWEIGHT
Multi-agent note output
MDLZ
Equity research — MDLZ (as of 2026-08-07)
Updated Aug 7, 2026
Coverage
MDLZ
Freshness
3 days ago
Market chart
Price context alongside the research narrative.
How the call aged
A simple read on whether this desk view matched what happened in the market over the next 5 trading days, with recent price context from the as-of date.
Desk view: OVERWEIGHTNot gradedVs peers: Weaker than mostAwaiting market data
Price move
—
2026-08-07 → awaiting data
5-day trend
+0.48%
20-day trend
+6.43%
Recent volatility
+29.69%
vs SPY (5d): -3.03%
Close 62.61 → —
Desk briefing
Mondelez (MDLZ) is a structural Overweight for the 12-month investment horizon. The company has confirmed operational momentum with a Q2 CY2026 revenue and EPS beat, raised its full-year organic growth guidance to at least +2%, and conti...
Full research note
Presentation-ready note with specialist analyst agents, bull and bear agent debate, trader agent synthesis, risk challenge, and portfolio sign-off.
WebserviceX.NET Research Desk
MDLZ Equity Research Note
Summary
Mondelez (MDLZ) is a structural Overweight for the 12-month investment horizon. The company has confirmed operational momentum with a Q2 CY2026 revenue and EPS beat, raised its full-year organic growth guidance to at least +2%, and conti...
Bias
OVERWEIGHT
Horizon
Short to medium term
Key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
Catalyst watch
This is guidance for execution only — it does not change the 12-month structural rating above.